Multi-layered container
US-2016303834-A1 · Oct 20, 2016 · US
US9908682B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9908682-B2 |
| Application number | US-201414475819-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 3, 2014 |
| Priority date | Jan 9, 2007 |
| Publication date | Mar 6, 2018 |
| Grant date | Mar 6, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Ampoules made of plastics material and containing 0.5 to 5 ml of a pharmaceutical formulation are sealed, together with an oxygen scavenger, within a pouch.
Opening claim text (preview).
The invention claimed is: 1. A method of reducing oxidative degradation of the contents of ampoules comprising the steps of: (a) preparing a plurality of ampoules consisting essentially of a plastics material and manufactured using a blow-fill-seal method under normal atmospheric conditions, wherein the ampoules contain a solution of an inhalation pharmaceutical in a pharmaceutically acceptable carrier, (b) sealing a packet or sachet comprising an oxygen scavenger and the plurality of ampoules in a resealable container under normal atmospheric conditions, wherein the resealable container is made of a material comprising a metal or metal compound and is gas impermeable; (c) unsealing the container under normal atmospheric conditions and removing one or more ampoules; and (d) resealing the container under normal atmospheric conditions while the packet or sachet comprising the oxygen scavenger and at least one ampoule remain in the container, wherein, in the absence of an oxygen scavenger, the plurality of ampoules and the resealable container maintain separate environments, and wherein a first oxygen concentration in a headspace of at least one ampoule prior to sealing in the resealable container is greater than a second oxygen concentration in the headspace of the at least one ampoule after sealing the resealable container. 2. The method of claim 1 wherein the plurality of ampoules is 10 or more ampoules. 3. The method of claim 1 wherein the oxygen scavenger can absorb 20 to 2000 cc of oxygen. 4. The method of claim 1 wherein the metal or metal compound is aluminum. 5. The method of claim 1 wherein the container is a pouch. 6. The method of claim 1 wherein the plurality of ampoules contain up to 10 mL of the solution of the inhalation pharmaceutical in the pharmaceutically acceptable carrier. 7. The method of claim 1 wherein the inhalation pharmaceutical comprises levalbuterol and ipratropium bromide.
Bag-type containers · CPC title
for absorbing gases, e.g. oxygen absorbers or desiccants (B65D51/244, B65D51/30 take precedence) · CPC title
Bronchodilators · CPC title
Flexible ampoules, the contents of which are expelled by squeezing · CPC title
the absorber being enclosed in a small pack, e.g. bag, included in the package · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.